Rapid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia

Laboratory Investigation

Volumn 84, Issue 2, 2004, Pages 263-266

  Ohsugi, Takeo ^a   Yamaguchi, Kazunari ^a   Kumasaka, Toshio ^b   Ishida, Takaomi ^c   Horie, Ryouichi ^c   Watanabe, Toshiki ^c   Sakio, Noboru ^a   Fujimoto, Toshio ^a   Sakamoto, Noriyuki ^a   Urano, Toru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

ATL; HTLV 1; SCID mice; Tumor death; Tumor formation

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DEATH; INOCULATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; AGE; ANIMAL; DRUG SCREENING; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; MORTALITY; MOUSE MUTANT; POLYMERASE CHAIN REACTION; SURVIVAL RATE; VIROLOGY; VIRUS CELL TRANSFORMATION;

BETA GLOBULIN; DNA; TAX PROTEIN;

AGE FACTORS; ANIMALS; BETA-GLOBULINS; CELL TRANSFORMATION, VIRAL; DNA, NEOPLASM; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOCOMPROMISED HOST; KILLER CELLS, NATURAL; LEUKEMIA, T-CELL; MALE; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 12144291318     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700034     Document Type: Article

References (17)

1. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-6480.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
3. Mori N, Fujii M, Ikeda S, et al. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood 1999;93:2360-2368.
4. Ishihara S, Tachibana N, Okayama A, et al. Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jpn J Cancer Res 1992;83:320-323.
5. Feuer G, Zack JA, Harrington Jr WJ, et al. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood 1993;82:722-731.
6. Kondo A, Imada K, Hattori T, et al. A model of in vivo cell proliferation of adult T-cell leukemia. Blood 1993;82:2501-2509.
7. Feuer G, Stewart SA, Baird SM, et al. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J Virol 1995;69:1328-1333.
8. Imada K, Takaori-Kondo A, Akagi T, et al. Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo. Blood 1995;86:2350-2357.
9. Tanaka T, Kitamura F, Nagasaka Y, et al. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med 1993;178:1103-1107.
10. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491.
11. Ohsugi T, Ishibashi K, Shingu M, et al. Engraftment of HTLV-I-transformed human T-cell line into SCID mice with NK cell function. J Vet Med Sci 1994;56:601-603.
12. Kiessling R, Hochman PS, Haller O, et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977;7:655-663.
13. Pflumio F, Lapidot T, Murdoch B, et al. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 1993;5:1509-1522.
14. Richard V, Lairmore MD, Green PL, et al. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression. Am J Pathol 2001;158:2219-2228.
15. Liu Y, Dole K, Stanley JR, et al. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. Leuk Res 2002;26:561-567.
16. Tan C, Waldmann TA. Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Cancer Res 2002;62:1083-1086.
17. null mice: suppression by an inhibitor against NF-κB. J Virol 2003;77:5286-5294.